Literature DB >> 31388199

Large cell neuroendocrine carcinoma of the submandibular gland: a case report and literature review.

M Mascitti1, E Luconi1, L Togni1, C Rubini2.   

Abstract

Neuroendocrine tumors (NET) are a heterogeneous group of malignancies with a broad spectrum of histomorphologies, tissue origins, and clinical outcomes, which arise from neural crest cells with neuroendocrine differentiation. Salivary gland tumors account for 3-6% of all head and neck neoplasms, while large cell neuroendocrine carcinomas (LCNEC) of the salivary gland are extremely rare, with few cases reported in literature, and only 5 cases involving submandibular gland. The rarity of these tumors in salivary glands is probably related to the scarcity of neuroendocrine cells in this tissue, whose presence is still a matter of debate. Regardless of their low frequency, it is imperative to differentiate these tumors from the much more common squamous cell carcinomas and metastatic NETs, due to different therapeutic approach and prognosis. In this paper, we report the case of a 21-year-old man, with a LCNEC involving a submandibular gland followed by several recurrences over the years. In addition, we include a comprehensive review of the available literature on this topic.
Copyright © 2019 Società Italiana di Anatomia Patologica e Citopatologia Diagnostica, Divisione Italiana della International Academy of Pathology.

Entities:  

Keywords:  LCNEC; Neuroendocrine tumors; Salivary gland; Submandibular gland

Mesh:

Year:  2019        PMID: 31388199     DOI: 10.32074/1591-951X-13-19

Source DB:  PubMed          Journal:  Pathologica        ISSN: 0031-2983


  2 in total

1.  Primary Large Cell Neuroendocrine Carcinoma of the Parotid Gland. Report of a Rare Case.

Authors:  Konstantinos I Tosios; Vasileios Papanikolaou; Dimitrios Vlachodimitropoulos; Nikolaos Goutas
Journal:  Head Neck Pathol       Date:  2021-02-05

2.  Nomograms Forecasting Long-Term Overall and Cancer Specific Survival of Patients With Head and Neck Neuroendocrine Carcinoma.

Authors:  Ouying Yan; Wenji Xie; Haibo Teng; Shengnan Fu; Yanzhu Chen; Feng Liu
Journal:  Front Oncol       Date:  2021-02-15       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.